Biocytogen Pharmaceuticals-B(02315) recommends appointing Liu Hongkang as a non-executive director
Bosaidoo (02315) announced that, following the nomination by the Nomination Committee and the approval by the Board of Directors, it was recommended at the Board meeting held on January 27, 2026 to appoint Mr. Liu Hongkang as a non-executive director.
Biocytogen Pharmaceuticals-B (02315) announced that, following the nomination by the Nomination Committee and approval by the Board of Directors, it was recommended at the Board meeting held on January 27, 2026 to appoint Mr. Liu Hongkang as a non-executive director.
Related Articles
On January 27, EDIANYUN (02416) spent 6.0868 million Hong Kong dollars to repurchase 2.096 million shares.
FU SHOU YUAN (01448): He Min is transferred from independent non-executive director to executive director.
PETRO-KING (02178) plans to sell 2 130-barrel mix sand trucks for 8.05 million yuan.
On January 27, EDIANYUN (02416) spent 6.0868 million Hong Kong dollars to repurchase 2.096 million shares.
FU SHOU YUAN (01448): He Min is transferred from independent non-executive director to executive director.
PETRO-KING (02178) plans to sell 2 130-barrel mix sand trucks for 8.05 million yuan.
RECOMMEND
New Record Achieved As Spot Gold Tops $5,000 For The First Time; Institutions Set $6,600 Target
27/01/2026
117 Companies Raised Over HKD 285.6 Billion Through IPOs As Hong Kong Reclaims Global Leadership In 2025
27/01/2026
“A+H Hong Kong Listing Requires RMB 30 Billion Market Cap”? On‑Site Inquiry Dispels The Rumor
27/01/2026
